Skip to main content

Advertisement

Log in

Abstract.

Integrins are a family of cell surface glycoproteins that mediate numerous cell-cell and cell-matrix interactions and are involved in biological processes such as tissue morphogenesis, leukocyte recirculation and migration, wound healing, blood clotting and immune response. Aberrant cell adhesion has been implicated in the pathogenesis of several diseases, including a number of inflammatory disorders such as rheumatoid arthritis, inflammatory bowel disease and asthma, as well as cancer and coronary heart disease. As such integrins are seen as excellent targets for the development of therapeutic agents. This report begins with an examination of the structure of integrin molecules and their ligands and then goes on to review the current state of development of antiintegrin antagonists.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received 13 April 1999; received after revision 28 May 1999; accepted 28 May 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Curley, G., Blum, H. & Humphries, M. Integrin antagonists. CMLS, Cell. Mol. Life Sci. 56, 427–441 (1999). https://doi.org/10.1007/s000180050443

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s000180050443

Navigation